Pompidou Group of the Council of Europe’s Post

https://lnkd.in/gCR6eWtq I think the article offers a thorough examination of international drug treaties and their influence on drug policy reform efforts. However, it could strengthen its impact by incorporating more personal narratives from those affected by punitive drug laws. This would help humanize the issue and emphasize the urgency of reform efforts.

What are drug schedules? Drug schedules are classifications used to categorize drugs, examining the balance between their usefulness and potential for harm. These schedules play a crucial role in the legal and regulatory framework surrounding controlled substances. In America, the United States Drug Enforcement Administration (DEA) is responsible for assigning drugs to their respective schedules, which range from Schedule 1 to Schedule 5. This includes both legal medications and the classification of illegal drugs. 💊 Read our blog for everything you need to know about drug schedules. https://lnkd.in/eaDzfuZE #Countrywidetesting #DrugAddiction #DrugSafety

🚨 Protecting Innovation and Public Health 🚨 In a global joint effort, Operation SHIELD IV, coordinated by Europol, successfully tackled the growing menace of counterfeit and misused medicines in the European Union and beyond. With 1,284 individuals charged and 52 organized crime groups investigated, this operation is a crucial step in safeguarding public health and preserving the integrity of intellectual property. 🔐 Intellectual Property matters! Counterfeit medicines not only pose a direct threat to public health but also erode the hard-earned innovations of pharmaceutical companies. Rasing awareness on this issue is crucial to ensure a secure and innovative future for all. EUIPO - European Union Intellectual Property Office Europol #OperationSHIELD #Counterfeit #PublicHealth #IntellectualProperty #RCFProtectingInnovation https://lnkd.in/dN4Y9rem

Explore Georgia's drug laws: Learn about the Four Schedules, Dangerous Drug Act, and other regulations. https://lnkd.in/gi4542YE

For more than 50 years, the Drug Enforcement Administration (DEA) has enforced the central mandate of the Controlled Substances Act (CSA) to maintain a closed chain of distribution for drugs with a potential for abuse and diversion. The CSA and regulations promulgated by DEA are intended to reduce the potential for diversion and abuse and ensure that controlled substances are dispensed and delivered to patients for a legitimate medical purpose. However, the well-intentioned statutory language enacted in 1970 did not anticipate important changes in clinical therapies and advances in medical technology, and in some cases has created obstacles both to ensuring needed patient access and successful medical outcomes. In a recent blog post, John Gilbert and Karla Palmer discuss the history of DEA guidance documents and how the Agency has indicated that it intends to issue new guidance. Read their blog post here: https://lnkd.in/gwhFdE7j #fda #fdalawblog #regulatory

Gross vs. Net Weight: Key Measurements in Drug Prosecutions Upon receipt of drug evidence, laboratory technicians weigh the substance. First, they calculate gross weight of the seized evidence, which includes both the substance and packaging material in which narcotics ae contained. Next, they remove all packaging materials in order to weigh only the actual narcotics resulting in a net weight. Net weight is less than gross weight, and only relates to the quantity of a narcotic, opposed to drugs plus packaging materials. Net weight is the measure used in criminal prosecutions to make charging decisions and to prove crimes. Net weight is also the measure relied upon by courts when imposing criminal sentences in drug cases. For more information: https://lnkd.in/eQPy28Af

Roar Mikalsen is an author and the founder of AROD, the Alliance for Rights-Orientated Drug Policy. He’s based in Norway and in recent years, has launched a campaign to force the Norwegian judiciary to deal with the issue of cannabis regulation.   In this short video (10 mins) he explains why European Courts has failed EU citizens on drug prohibition in 2012, why national drug policies are an infringement of human rights, why decriminalization is not the answer and why governments must take responsibility through the regulation of markets. We also touch on the obstacles faced by Germany in the run up to legalization.   This is an issue that affects every cannabis user.   Find Roar on LinkedIn here: https://lnkd.in/e3erpdGj   #cannabisculture #weedculture #cannabisstigma #cannabisreform #druglaw #drugreform #drugprohibition #legalization #germany #humanrights

𝐃𝐫𝐮𝐠 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 & 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 Download PDF Brochure @ https://lnkd.in/d4v4Jhqy Drug Screening Market is projected to reach USD 19.5 billion by 2029, from USD 9.1 billion in 2024, at a CAGR of 16.6%. Drug abuse and alcohol consumption are growing worldwide. According to the 𝐖𝐨𝐫𝐥𝐝 𝐃𝐫𝐮𝐠 𝐑𝐞𝐩𝐨𝐫𝐭 2023, in 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The number of users grew from 240 million in 2011 to 296 million in 2021 or 5.8% of the global population aged 15-64. This is a 23% increase, partly due to population growth. Other drugs like Cannabis the second most used drug, with an estimated 219 million users i.e. 4.3% of the global adult population in 2021. In 2021, according to the U.S. Department of Transportation, National Highway Traffic Safety Administration NHTSA (NHTSA), 13,384 people died in alcohol-impaired driving crashes, i.e. a 14% rise from last year. The expanding consumption of illicit drugs & alcohol will advance raise the development of drug screening products & services on the road, thereby driving the overall market growth. #AsiaPacific drug screening market is anticipated to witness the fastest growth over the forecast period. Several key trends are reshaping the landscape of the drug testing market in the Asia Pacific. One prominent trend is the increasing focus on preventing the consumption of illicit drug consumption. Healthcare providers as well as government authorities in Asia Pacific recognize the importance of spreading awareness about the harmful effects of illicit drugs. The drug screening market in #China is expected to grow over the forecast period due to the rise in drug abuse, especially alcohol and illicit drug abuse, which is very common among youngsters. Moreover, the growth of the market can also be attributed to the increasing number of product launches and growing availability of rapid test kits. #Japan Drug screening Market is expected to grow over the forecast period. This is attributable to the government making collaborative efforts to boost drug testing in the region. In October 2023, the 𝐉𝐚𝐩𝐚𝐧𝐞𝐬𝐞 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 dispensed drug screening kits to the Maldives Customs Service and 𝐌𝐚𝐥𝐝𝐢𝐯𝐞𝐬 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐟𝐞𝐧𝐬𝐞 𝐅𝐨𝐫𝐜𝐞 (𝐌𝐍𝐃𝐅). Labcorp, Quest Diagnostics, AbbottVision, Thermo Fisher Scientific, Alfa Scientific Designs, Inc., OraSure Technologies , Siemens Healthineers, MPD, Inc. , SHIMADZU CORPORATION, Lifeloc Technologies, Drägerwerk AG & Co. KGaA, Premier Biotech, Omega Laboratories, Inc., Psychemedics Corporation, Clinical Reference Laboratory, American Bio Medica Corporation (ABMC), ACM Global Laboratories, CareHealth America Corp -A WHPM Company, Sciteck, Inc., Intoximeters, AccuSourceHR, Inc., Cordant Health Solutions, Intoxalock, Millennium Health

Chart of the day: News broke Tuesday that the U.S. Drug Enforcement Administration is moving to reclassify marijuana to a Schedule III controlled substance. According to CivicScience data, nearly half of Americans think favorably of the effort. Full story: https://hubs.la/Q02w0l6f0 #CivicScience #insights #data #trends #intelligence #marketresearch #mrx #consumerbehavior #consumerinsights #consumerintelligence

Yes, there are instances where regulation has contributed to reducing the illegal drug trade. For example: - **Canada**: The country has seen a reduction in the illegal drug market by implementing legal regulatory mechanisms. This approach has helped address public health concerns and the unsafe drug supply caused by a lack of regulation¹. - **United States**: Research suggests that criminalizing people who sell or distribute drugs has not reduced drug use or availability. Instead, shifting towards policies that reduce punishment and provide support for those involved in the drug trade can lead to better outcomes². - **Financial Strategies**: Targeting the financial networks of drug cartels has been a critical strategy. By working with financial institutions to track and freeze illicit funds, governments have made strides in combating drug trafficking³. These examples show that through innovative regulatory approaches and strategic financial interventions, it is possible to impact the illegal drug trade positively. Source: Conversation with Bing, 4/1/2024 (1) The regulation project: Tools for engaging the public in the legal .... https://lnkd.in/gaNQSveN. (2) More About People in the Drug Trade - Drug Policy Alliance. https://lnkd.in/gmhaTp3F. (3) The War on Drugs: Challenges and Strategies in Combating Trafficking. https://lnkd.in/gDme3xm8.